CA 19-9 Antigen
CA 19-9 antigen is a heterogenous glycoprotein, whose elevated levels are observed in the serum of patients with colorectal as well as pancreatic, gastric and liver cancer. Increased levels, but to a lesser extent, are detected in some breast, ovary, lung and head and neck cancers. The determination of CA 19-9 antigen can be used for prognosis and monitoring of pancreatic cancer.
| Name | IRMA CA 19-9 antigen |
| Ref. | B64313/IM3151 |
| Method | IRMA |
| Type | Coated tubes |
| Tests | 50/100 |
| Max. Activity (kBq) | 310 |
| Sensitivity (LoD) | 6.45 U/mL |
| Incubation conditions | 2 hrs+1 hr/RT;shaking |
| Calibrator range | 0;15-480 U/mL |
| Sample volume (μL) | 50 |
| Sample form | serum |
| Analyte info |  |
| Instructions for Use | |
| MSDS | |